Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced that Dr. Francesca Serraino Fiory will serve as the company’s new chief scientific officer. In her new role, Fiory will manage product development, including GRYN’s multibrand portfolio, and oversee research and development efforts under TruLife Biotech, the company’s wholly owned subsidiary. In addition, she will head up partnerships with both academic institutions and research centers and will navigate the company across the global regulatory landscape. Fiory has worked for several major players in the pharmaceutical industry including Pfizer, where she started in regulatory and medical affairs; Johnson and Johnson (“J&J”), where she was head of regulatory and medical affairs at Johnson & Johnson Consumer Health Care, Italy; and Perrigo Pharma, where she was director of regulatory, quality and medical affairs and also supervised the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. A certified nutritional consultant, clinical master herbalist and aromatherapist, and a certified holistic health practitioner in traditional Chinese medicine, Fiory brings with her 20-plus years of expertise and an impressive knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.
To view the full press release, visit https://ibn.fm/HGlEc
About Green Hygienics Holdings Inc.
Green Hygienics is a California-based innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with consumer packaged goods (“CPG”) and pharmaceutical companies. For more information about the company, visit www.GreenHygienics.com.
NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.